Chronic tinnitus affects approximately 10-15% of the population, causing persistent ringing, buzzing, or other phantom sounds that significantly impact quality of life, concentration, and emotional wellbeing. When traditional treatments like sound therapy and medications haven’t provided adequate relief, transcranial magnetic stimulation (TMS) offers an evidence-based alternative. At Complete Mind Care of PA, our experienced team of over 20 board-certified providers offers advanced neuromodulation treatments for tinnitus as part of comprehensive brain wellness care.
Our leadership team brings extensive experience from building a successful 35-location TMS practice, giving us deep expertise in neuromodulation treatments. We serve more than 4,500 active patients across our Horsham and Villanova locations with extended hours (7 AM – 8 PM weekdays) to accommodate your schedule.
We understand that chronic tinnitus affects every aspect of life—work concentration, sleep quality, emotional health, and social engagement. Remission is our mission, and we’re committed to exploring evidence-based approaches that may help reduce the perception and severity of tinnitus.
Tinnitus is the perception of sound in the absence of any external auditory stimulation. For most people, tinnitus is subjective—only the person experiencing it can hear the phantom sound. Approximately 20% of adults with tinnitus require clinical intervention, and the condition can become chronic and severely affect quality of life in 1-3% of the general population.
Sound Perceptions:
Impact on Daily Life:
Hearing Loss and Auditory Damage: The most common association is with hearing loss or damage to the auditory system, including age-related hearing loss, noise-induced hearing loss from occupational or recreational exposure, ototoxic medications (certain antibiotics, cancer treatments, high-dose aspirin), head trauma affecting the ear or auditory nerve, and ear infections or diseases.
Other Contributing Factors: Temporomandibular joint (TMJ) disorders, neck injuries or whiplash, cardiovascular conditions, Meniere’s disease, acoustic neuroma (vestibular schwannoma), stress and anxiety, and certain medications.
Idiopathic Cases: In many cases, a specific cause cannot be identified, though the condition is still understood to involve changes in the central nervous system’s auditory processing.
Contemporary research understands chronic tinnitus not as a simple ear problem, but as a neurological condition involving maladaptive changes in the brain. Even when tinnitus originates from peripheral auditory damage, the phantom perception is generated and maintained by alterations in central brain networks.
Central Nervous System Changes: While tinnitus may be triggered by peripheral auditory damage (such as noise exposure), the observation that transection of the auditory nerve does not abolish tinnitus clearly indicates its central nervous system origin. Research shows:
Neuronal hyperactivity: Functional imaging studies reveal abnormal increases in neural activity within the auditory cortex and temporoparietal regions. This hyperactivity represents spontaneous firing of neurons in the absence of actual sound input.
Maladaptive neuroplasticity: After sensory deafferentation (loss of normal auditory input from the ear), the auditory cortex undergoes plastic changes. These include alterations in neuronal firing patterns, changes in burst firing and neural synchrony, and cortical tonotopic map reorganization—where the brain’s frequency mapping becomes distorted.
Network-level changes: Tinnitus involves not just the auditory cortex but an extended neuronal network. Functional imaging shows alterations in the primary auditory cortex, higher-order association areas, and parts of the limbic system. Non-auditory brain areas are also involved, representing both an “awareness” network involved in conscious perception of tinnitus and a distress network (anterior cingulate cortex, anterior insula, amygdala) related to the emotional reaction to tinnitus.
Memory and reinforcement: The hippocampus and parahippocampal regions may play a role in the persistence of tinnitus awareness and the reinforcement of associated distress, explaining why tinnitus can become more intrusive and bothersome over time.
Reduced inhibitory control: Studies show decreased inhibitory neurotransmission (GABA) and altered balance between excitatory and inhibitory circuits in the auditory pathways and cortex.
Standard tinnitus management includes sound therapy and masking devices, hearing aids (for those with hearing loss), cognitive behavioral therapy to reduce distress and develop coping strategies, tinnitus retraining therapy combining sound therapy with counseling, relaxation and stress management techniques, and medications for associated anxiety or depression. However, these approaches focus primarily on managing reactions to tinnitus rather than reducing the perception itself. Many individuals need additional treatment options that target the underlying neural mechanisms.
Important Note: TMS is not FDA-approved for treating tinnitus. At Complete Mind Care of PA, we offer TMS for tinnitus as an advanced treatment option based on research evidence showing potential benefit in a subset of patients. This treatment is provided on a cash-pay basis and should be viewed as complementary to standard tinnitus management, not a replacement for comprehensive care.
Research has primarily focused on low-frequency repetitive TMS (rTMS) targeting brain regions involved in tinnitus:
Temporoparietal Cortex/Secondary Auditory Cortex: The most extensively studied target. This region, located where the temporal and parietal lobes meet, shows abnormal hyperactivity in tinnitus patients. Low-frequency stimulation (typically 1 Hz) aims to reduce this excessive neural activity.
Primary Auditory Cortex: Some protocols target Heschl’s gyrus and surrounding primary auditory areas, though this region may be too deep for standard TMS coils to effectively reach in some individuals.
Dorsolateral Prefrontal Cortex (DLPFC): An alternative or adjunctive target, particularly when depression or distress is prominent. May help modulate the emotional and attentional aspects of tinnitus.
Low-frequency rTMS works by suppressing hyperactive neural circuits, modulating synaptic plasticity in auditory networks, normalizing abnormal firing patterns, and reducing the conscious awareness and distress associated with tinnitus perception.
Chronic tinnitus involves dysfunction in the brain’s auditory processing systems, characterized by hyperactivity, maladaptive plasticity, and altered network connectivity. Neuroimaging and neurophysiological studies demonstrate that individuals with chronic tinnitus show:
TMS delivers magnetic pulses through a coil placed on the scalp, creating electrical currents that modulate neural activity. Low-frequency stimulation protocols work through multiple mechanisms:
Suppression of cortical hyperactivity: Low-frequency rTMS (1 Hz) has inhibitory effects that reduce excessive neural activity in the auditory cortex and temporoparietal regions. Functional imaging studies show TMS decreases the abnormal hyperactivity associated with tinnitus perception, potentially reducing the loudness and awareness of phantom sounds.
Modulation of neural synchrony: Tinnitus involves abnormal synchronization of neural firing—neurons firing together in patterns that create the perception of sound where none exists. TMS can disrupt these pathological firing patterns, temporarily interrupting the neural circuits that generate tinnitus.
Restoration of inhibitory control: TMS modulates the balance between excitatory and inhibitory neurotransmission. By enhancing inhibitory (GABAergic) activity, rTMS helps restore the normal checks and balances that should suppress spontaneous neural activity in the auditory system.
Neuroplastic changes: Repeated rTMS sessions induce lasting changes in synaptic strength and neural connectivity. These neuroplastic adaptations may help reverse some of the maladaptive changes that developed after auditory damage, potentially providing sustained tinnitus reduction.
Enhancement of alpha oscillations: Research shows tinnitus relief after rTMS is associated with increased alpha power in the auditory cortex. Alpha oscillations help suppress irrelevant neural signals and reduce conscious perception of phantom sounds.
Modulation of tinnitus-distress networks: By influencing interconnected brain regions including the limbic system, TMS may reduce not only the perception of tinnitus but also the emotional distress and negative reactions to it.
Interruption of neural loops: TMS temporarily disrupts the neural activity in targeted cortical areas, interrupting the self-sustaining loops of activity that maintain chronic tinnitus perception.
The evidence base for TMS in tinnitus shows promising but variable results:
A comprehensive systematic review and meta-analysis published in BMC Psychiatry examined 29 randomized controlled trials involving 1,228 chronic tinnitus patients. Compared with sham stimulation, active rTMS showed significant improvements in Tinnitus Handicap Inventory (THI) scores at 1 week (mean reduction of 7.92 points), 1 month (mean reduction of 8.52 points), and 6 months (mean reduction of 6.53 points) post-treatment. The treatment was well-tolerated with minimal adverse effects.
A landmark randomized clinical trial published in JAMA Otolaryngology examined 64 participants with chronic tinnitus who received either active or placebo rTMS (2000 pulses per session at 1 Hz, daily for 10 consecutive workdays) targeted to the temporoparietal cortex. Overall, 56% of participants (18 of 32) in the active rTMS group were responders to treatment, compared to only 22% (7 of 32) in the placebo group—representing a statistically significant benefit. Follow-up assessments conducted at 1, 2, 4, 13, and 26 weeks after treatment showed sustained improvements lasting at least 6 months in many responders. No participants withdrew due to adverse effects. A significant number of participants who had tinnitus for more than 20 years experienced relief, representing the first symptom improvement in years for some individuals.
A 2025 systematic review and meta-analysis published in Frontiers in Neuroscience concluded that rTMS has some efficacy in chronic tinnitus, with positive short-term effects on tinnitus severity and quality of life. However, the analysis noted that long-term effects (6 months) were less consistent, and more high-quality trials are needed to validate effectiveness and establish standardized protocols.
Research examining PET-guided rTMS (individually navigated to areas of maximal tinnitus-related brain hyperactivity) showed dose-dependent tinnitus reduction lasting up to 30 minutes after single sessions, with effects negatively correlated with tinnitus duration—suggesting earlier intervention may yield better results.
Studies comparing different stimulation sites show that the auditory cortex and temporoparietal junction are the most commonly targeted locations, with low-frequency (1 Hz) stimulation over 10 consecutive days being the most widely used protocol. Multi-site stimulation targeting both auditory regions and prefrontal cortex shows promise but requires further investigation.
It’s essential to understand that TMS research for tinnitus shows moderate effect sizes and high individual variability. While some patients experience significant and lasting tinnitus reduction, others show minimal or no response. Factors that may influence response include tinnitus duration (shorter duration appears more responsive), presence of hearing loss (normal hearing may respond better), severity at baseline (higher severity scores may predict better response), and whether comorbid depression is present.
Treatment begins with thorough assessment by our board-certified psychiatrists or psychiatric nurse practitioners. We’ll review:
We’ll conduct standardized tinnitus assessments including the Tinnitus Handicap Inventory (THI) or Tinnitus Functional Index (TFI). We’ll determine the most appropriate TMS protocol for your specific presentation and rule out contraindications.
TMS protocols for tinnitus typically involve:
Target: Temporoparietal cortex (secondary auditory cortex), contralateral or ipsilateral to the primary tinnitus location
Frequency: Low-frequency stimulation at 1 Hz (inhibitory protocol to reduce cortical hyperactivity)
Intensity: 110-120% of your resting motor threshold
Pulses: 600-2000 pulses per session
Induction phase: Daily sessions Monday through Friday for 2 weeks (10 sessions)
Maintenance phase: Some protocols include additional weekly or monthly sessions
Session duration: 10-30 minutes depending on the protocol
Our team will design a personalized protocol based on current research evidence, your specific tinnitus characteristics, and treatment goals.
You’ll sit comfortably in a recliner while the TMS coil is positioned over your scalp targeting the temporoparietal region. The treatment produces clicking sounds and creates a tapping sensation on your scalp. Most patients tolerate this well. You’ll remain awake and alert throughout treatment—many patients read, listen to music (at appropriate volumes), or simply relax. You can drive yourself to and from appointments and resume normal activities immediately.
We use standardized assessments to track changes in:
Regular check-ins help us understand how treatment is affecting your tinnitus perception and adjust our approach as needed.
Tinnitus response to rTMS varies considerably between individuals. Some patients notice temporary reduction in tinnitus loudness or awareness during or immediately after sessions. More lasting improvements typically emerge over the course of the 10-session treatment period.
Based on clinical trial data, responders often show improvements that persist through follow-up assessments at 1 month, 3 months, and 6 months after treatment. Some studies report effects lasting from several days to several months. The duration of tinnitus appears to matter—patients with shorter tinnitus duration may respond better than those with decades-long tinnitus.
It’s important to understand that not all patients respond to TMS for tinnitus. Research shows approximately 40-56% of patients experience clinically meaningful improvement, meaning a substantial proportion do not achieve significant benefit from this treatment.
TMS for tinnitus may be appropriate if you:
Research suggests TMS may work best for:
FDA status: TMS for tinnitus is investigational and not FDA-approved. Evidence shows potential benefit in a subset of patients, but results are variable and effect sizes are moderate. Ongoing research is needed to optimize protocols, identify who responds best, and understand mechanisms more fully.
Individual variability: Response to TMS for tinnitus is highly variable. While some patients experience significant, lasting reduction in tinnitus perception and severity, others show minimal or no response. Approximately 40-56% of patients in clinical trials achieved meaningful improvement. This means nearly half of patients may not benefit significantly.
Not a replacement for comprehensive care: TMS should complement, not replace, standard tinnitus management including sound therapy, counseling, hearing aids (if hearing loss is present), and appropriate management of underlying conditions. Continue all treatments recommended by your audiologist or otolaryngologist.
Effects may be temporary: When tinnitus reduction occurs, duration of benefit varies. Some patients experience effects lasting days to weeks, while others maintain improvements for months. Maintenance sessions may help extend benefits, though optimal maintenance schedules are not well-established.
Tinnitus duration matters: Research suggests patients with more recent onset tinnitus (months to a few years) may respond better than those with decades-long tinnitus. However, some long-term sufferers have experienced benefit in clinical trials.
Hearing status matters: Some evidence suggests patients with normal hearing or mild hearing loss may respond better than those with significant hearing loss. Hearing loss may represent an ongoing trigger that reduces and shortens TMS treatment effects.
Time and financial commitment: A full protocol involves 10 sessions over 2 weeks. This requires scheduling flexibility and financial resources. Our extended hours help accommodate work schedules.
Research limitations: TMS for tinnitus research faces challenges including heterogeneity in study protocols, small sample sizes in some studies, variability in outcome measures, and uncertainty about optimal stimulation parameters. Large-scale, multi-site clinical trials are needed to determine which protocols work best and for whom.
We recognize that chronic tinnitus can be isolating and frustrating. Many patients have tried multiple treatments without relief, and the constant phantom sound can feel overwhelming. Our team provides understanding, evidence-based care that respects the real neurological basis of your condition.
We understand that tinnitus affects every aspect of life—work concentration, sleep quality, emotional health, relationships, and enjoyment of activities. Our goal is reducing the perception and severity of tinnitus so you can reclaim peace and quality of life.
Our comfortable, private treatment rooms offer a calm environment. We work collaboratively with your existing healthcare providers—audiologists, otolaryngologists, and primary care physicians—to ensure comprehensive care. All TMS sessions are supervised by our trained clinical staff with immediate access to our board-certified psychiatric providers who have extensive experience in neuromodulation.
Because TMS for tinnitus is not FDA-approved for this indication, this treatment is not covered by insurance and is provided on a cash-pay basis. We provide transparent pricing during your consultation so you can make informed decisions about whether this investment aligns with your healthcare priorities.
Given the significant financial commitment, investigational nature, and variable outcomes of this treatment, we encourage careful consideration and discussion with your medical team before proceeding. Our team can provide documentation for any reimbursement requests you wish to pursue with your insurance carrier, though coverage is unlikely.
If you’re struggling with chronic tinnitus that hasn’t responded adequately to traditional management, or you’re looking for an evidence-based approach to reduce tinnitus perception, we’re here to help you understand whether TMS might be appropriate for your situation.
We serve patients throughout Montgomery and Delaware Counties, including communities along the Main Line, Abington, Dresher, and surrounding areas.
Clinical trials show variable results. A major study published in JAMA showed 56% of participants receiving active TMS were responders (experienced meaningful improvement) compared to 22% receiving placebo treatment—representing significant benefit. A meta-analysis of 29 studies showed average improvements of 7-8 points on the Tinnitus Handicap Inventory. However, this also means approximately 40-50% of patients may not experience significant benefit. Individual response is highly variable.
When tinnitus reduction occurs, duration varies significantly between individuals. Clinical trials show some patients maintain improvements for 6 months or longer after treatment. Others experience shorter-duration benefits lasting weeks to months. Some patients benefit from periodic maintenance sessions. Factors like tinnitus duration and hearing status may influence how long benefits last.
Learn more about research on transcranial magnetic stimulation for tinnitus:
Disclaimer: TMS for tinnitus is an investigational treatment approach and is not FDA-approved for this indication. Individual results vary significantly, with approximately 40-56% of patients experiencing meaningful improvement in clinical trials. This treatment should be viewed as complementary to, not replacement for, standard tinnitus management including sound therapy, hearing aids, and counseling. This information is for educational purposes and does not constitute medical advice. Consult with qualified healthcare providers specializing in audiology and otolaryngology to determine if TMS is appropriate for your situation.
Conditions Treated
721 Dresher Rd # 1100, Horsham, PA 19044
721 Dresher Rd # 1100, Horsham, PA 19044
Complete Mind Care was founded on the premise of providing full mental health support delivered by a team of expert professionals, in the comfort of a world-class facility local to you—so you can build a foundation for lasting recovery close to home. Plus 40+ additional insurance carriers accepted.
Don’t see your insurance listed? Call our office at 215-607-7250 or 215-918-7939 to verify coverage.
